 | • レポートコード：MRC2-11QY03916 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はナチュラルキラー細胞療法のグローバル市場について調査・分析したレポートです。種類別（NK細胞療法、NK細胞指向性抗体）市場規模、用途別（がん、胃腸疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ナチュラルキラー細胞療法の競争状況、市場シェア ・世界のナチュラルキラー細胞療法市場：種類別市場規模 2015年-2020年（NK細胞療法、NK細胞指向性抗体） ・世界のナチュラルキラー細胞療法市場：種類別市場規模予測 2021年-2026年（NK細胞療法、NK細胞指向性抗体） ・世界のナチュラルキラー細胞療法市場：用途別市場規模 2015年-2020年（がん、胃腸疾患、その他） ・世界のナチュラルキラー細胞療法市場：用途別市場規模予測 2021年-2026年（がん、胃腸疾患、その他） ・北米のナチュラルキラー細胞療法市場分析：米国、カナダ ・ヨーロッパのナチュラルキラー細胞療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのナチュラルキラー細胞療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のナチュラルキラー細胞療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのナチュラルキラー細胞療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Nektar Therapeutics、Innate Pharma SA、Affimed、Chipscreen Biosciences、Glycostem Therapeutics、Fate Therapeutics、Dragonfly Therapeutics、Kiadis Pharma、Nkarta Therapeutics、NantKwest ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cell therapy, a new therapeutic approach that uses a patient’s own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body’s first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
Market Analysis and Insights: Global Natural Killer Cell Therapy Market
The global Natural Killer Cell Therapy market size is projected to reach US$ 608.8 million by 2026, from US$ 206 million in 2020, at a CAGR of 24.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Natural Killer Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Natural Killer Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Natural Killer Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Natural Killer Cell Therapy market.
Global Natural Killer Cell Therapy Scope and Market Size
Natural Killer Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Natural Killer Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
NK Cell Therapies
NK Cell Directed Antibodies
Market segment by Application, split into
Cancer
Gastrointestinal Diseases
Others
Based on regional and country-level analysis, the Natural Killer Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Natural Killer Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapy Market Share by Application: 2020 VS 2026
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapy Market Perspective (2015-2026)
2.2 Global Natural Killer Cell Therapy Growth Trends by Regions
2.2.1 Natural Killer Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Natural Killer Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cell Therapy Players by Market Size
3.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Natural Killer Cell Therapy Revenue
3.4 Global Natural Killer Cell Therapy Market Concentration Ratio
3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2019
3.5 Key Players Natural Killer Cell Therapy Area Served
3.6 Key Players Natural Killer Cell Therapy Product Solution and Service
3.7 Date of Enter into Natural Killer Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cell Therapy Breakdown Data by Type (2015-2026)
4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Natural Killer Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2015-2020)
5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Natural Killer Cell Therapy Market Size (2015-2026)
6.2 North America Natural Killer Cell Therapy Market Size by Type (2015-2020)
6.3 North America Natural Killer Cell Therapy Market Size by Application (2015-2020)
6.4 North America Natural Killer Cell Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Natural Killer Cell Therapy Market Size (2015-2026)
7.2 Europe Natural Killer Cell Therapy Market Size by Type (2015-2020)
7.3 Europe Natural Killer Cell Therapy Market Size by Application (2015-2020)
7.4 Europe Natural Killer Cell Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Natural Killer Cell Therapy Market Size (2015-2026)
8.2 China Natural Killer Cell Therapy Market Size by Type (2015-2020)
8.3 China Natural Killer Cell Therapy Market Size by Application (2015-2020)
8.4 China Natural Killer Cell Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
(2015-2020)
(2015-2020)
.4 Natural Killer Cell Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
.4 Natural Killer Cell Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
9 Key Players Profiles
9.1 Nektar Therapeutics
9.1.1 Nektar Therapeutics Company Details
9.1.2 Nektar Therapeutics Business Overview
9.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
9.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020))
9.1.5 Nektar Therapeutics Recent Development
9.2 Innate Pharma SA
9.2.1 Innate Pharma SA Company Details
9.2.2 Innate Pharma SA Business Overview
9.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
9.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.2.5 Innate Pharma SA Recent Development
9.3 Affimed
9.3.1 Affimed Company Details
9.3.2 Affimed Business Overview
9.3.3 Affimed Natural Killer Cell Therapy Introduction
9.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.3.5 Affimed Recent Development
9.4 Chipscreen Biosciences
9.4.1 Chipscreen Biosciences Company Details
9.4.2 Chipscreen Biosciences Business Overview
9.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
9.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.4.5 Chipscreen Biosciences Recent Development
9.5 Glycostem Therapeutics
9.5.1 Glycostem Therapeutics Company Details
9.5.2 Glycostem Therapeutics Business Overview
9.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
9.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.5.5 Glycostem Therapeutics Recent Development
9.6 Fate Therapeutics
9.6.1 Fate Therapeutics Company Details
9.6.2 Fate Therapeutics Business Overview
9.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
9.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.6.5 Fate Therapeutics Recent Development
9.7 Dragonfly Therapeutics
9.7.1 Dragonfly Therapeutics Company Details
9.7.2 Dragonfly Therapeutics Business Overview
9.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
9.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.7.5 Dragonfly Therapeutics Recent Development
9.8 Kiadis Pharma
9.8.1 Kiadis Pharma Company Details
9.8.2 Kiadis Pharma Business Overview
9.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
9.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.8.5 Kiadis Pharma Recent Development
9.9 Nkarta Therapeutics
9.9.1 Nkarta Therapeutics Company Details
9.9.2 Nkarta Therapeutics Business Overview
9.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
9.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.9.5 Nkarta Therapeutics Recent Development
9.10 NantKwest
9.10.1 NantKwest Company Details
9.10.2 NantKwest Business Overview
9.10.3 NantKwest Natural Killer Cell Therapy Introduction
9.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2015-2020)
9.10.5 NantKwest Recent Development
10 Analyst’s Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details
Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of NK Cell Therapies
Table 4. Key Players of NK Cell Directed Antibodies
Table 5. Global Natural Killer Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Natural Killer Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Natural Killer Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Natural Killer Cell Therapy Market Share by Regions (2015-2020)
Table 9. Global Natural Killer Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Natural Killer Cell Therapy Market Share by Regions (2021-2026)
Table 11. Natural Killer Cell Therapy Market Market Trends
Table 12. Natural Killer Cell Therapy Market Drivers
Table 13. Natural Killer Cell Therapy Market Challenges
Table 14. Natural Killer Cell Therapy Market Restraints
Table 15. Global Natural Killer Cell Therapy Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Natural Killer Cell Therapy Market Share by Players (2015-2020)
Table 17. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cell Therapy as of 2019)
Table 18. Global Natural Killer Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Natural Killer Cell Therapy Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Natural Killer Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Natural Killer Cell Therapy Market Size Share by Type (2015-2020)
Table 24. Global Natural Killer Cell Therapy Revenue Market Share by Type (2021-2026)
Table 25. Global Natural Killer Cell Therapy Market Size Share by Application (2015-2020)
Table 26. Global Natural Killer Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Natural Killer Cell Therapy Market Size Share by Application (2021-2026)
Table 28. North America Natural Killer Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Natural Killer Cell Therapy Market Share by Type (2015-2020)
Table 30. North America Natural Killer Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Natural Killer Cell Therapy Market Share by Application (2015-2020)
Table 32. North America Natural Killer Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Natural Killer Cell Therapy Market Share by Country (2015-2020)
Table 34. Europe Natural Killer Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Natural Killer Cell Therapy Market Share by Type (2015-2020)
Table 36. Europe Natural Killer Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Natural Killer Cell Therapy Market Share by Application (2015-2020)
Table 38. Europe Natural Killer Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Natural Killer Cell Therapy Market Share by Country (2015-2020)
Table 40. China Natural Killer Cell Therapy Market Size by Type (2015-2020) (US$ Million)
Table 41. China Natural Killer Cell Therapy Market Share by Type (2015-2020)
Table 42. China Natural Killer Cell Therapy Market Size by Application (2015-2020) (US$ Million)
Table 43. China Natural Killer Cell Therapy Market Share by Application (2015-2020)
Table 44. China Natural Killer Cell Therapy Market Size by Region (US$ Million) (2015-2020)
Table 45. China Natural Killer Cell Therapy Market Share by Region (2015-2020)
Table 46. Natural Killer Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 47. Natural Killer Cell Therapy Market Share by Country (2015-2020)
Table 48. Natural Killer Cell Therapy Market Size by Country (US$ Million) (2015-2020)
Table 49. Natural Killer Cell Therapy Market Share by Country (2015-2020)
Table 50. Nektar Therapeutics Company Details
Table 51. Nektar Therapeutics Business Overview
Table 52. Nektar Therapeutics Product
Table 53. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 54. Nektar Therapeutics Recent Development
Table 55. Innate Pharma SA Company Details
Table 56. Innate Pharma SA Business Overview
Table 57. Innate Pharma SA Product
Table 58. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 59. Innate Pharma SA Recent Development
Table 60. Affimed Company Details
Table 61. Affimed Business Overview
Table 62. Affimed Product
Table 63. Affimed Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 64. Affimed Recent Development
Table 65. Chipscreen Biosciences Company Details
Table 66. Chipscreen Biosciences Business Overview
Table 67. Chipscreen Biosciences Product
Table 68. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 69. Chipscreen Biosciences Recent Development
Table 70. Glycostem Therapeutics Company Details
Table 71. Glycostem Therapeutics Business Overview
Table 72. Glycostem Therapeutics Product
Table 73. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 74. Glycostem Therapeutics Recent Development
Table 75. Fate Therapeutics Company Details
Table 76. Fate Therapeutics Business Overview
Table 77. Fate Therapeutics Product
Table 78. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 79. Fate Therapeutics Recent Development
Table 80. Dragonfly Therapeutics Company Details
Table 81. Dragonfly Therapeutics Business Overview
Table 82. Dragonfly Therapeutics Product
Table 83. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 84. Dragonfly Therapeutics Recent Development
Table 85. Kiadis Pharma Business Overview
Table 86. Kiadis Pharma Product
Table 87. Kiadis Pharma Company Details
Table 88. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 89. Kiadis Pharma Recent Development
Table 90. Nkarta Therapeutics Company Details
Table 91. Nkarta Therapeutics Business Overview
Table 92. Nkarta Therapeutics Product
Table 93. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 94. Nkarta Therapeutics Recent Development
Table 95. NantKwest Company Details
Table 96. NantKwest Business Overview
Table 97. NantKwest Product
Table 98. NantKwest Revenue in Natural Killer Cell Therapy Business (2015-2020) (US$ Million)
Table 99. NantKwest Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. NK Cell Therapies Features
Figure 3. NK Cell Directed Antibodies Features
Figure 4. Global Natural Killer Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Gastrointestinal Diseases Case Studies
Figure 7. Others Case Studies
Figure 8. Natural Killer Cell Therapy Report Years Considered
Figure 9. Global Natural Killer Cell Therapy Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Natural Killer Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Natural Killer Cell Therapy Market Share by Regions (2021-2026)
Figure 12. Global Natural Killer Cell Therapy Market Share by Players in 2019
Figure 13. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cell Therapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2019
Figure 15. North America Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Natural Killer Cell Therapy Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 43. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 44. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 45. Chipscreen Biosciences Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 46. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 47. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 48. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 49. Kiadis Pharma Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 50. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 51. NantKwest Revenue Growth Rate in Natural Killer Cell Therapy Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 多発性骨髄腫に対するCAR-T細胞療法の世界市場（～2026年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…